Table I.
miR-650 expression and clinicopathological features in 49 non-small cell lung cancer.
| miR-650 expression | ||||
|---|---|---|---|---|
| Clinicopathological features | Cases (n=49) | 26 High (%) | 23 Low (%) | P-valuea |
| Sex | 0.469 | |||
| Male | 25 | 12 (48.0) | 13 (52.0) | |
| Female | 24 | 14 (58.3) | 10 (41.7) | |
| Age (years) | 0.648 | |||
| ≤60 | 23 | 13 (56.5) | 10 (43.5) | |
| >60 | 26 | 13 (50.0) | 13 (50.0) | |
| Tumor size (mm) | 0.124 | |||
| ≤5.0 | 27 | 17 (63.0) | 10 (37.0) | |
| >5.0 | 22 | 9 (40.9) | 13 (59.1) | |
| TNM stage | 0.016a | |||
| I–II | 26 | 18 (69.2) | 8 (30.8) | |
| III–IV | 23 | 8 (34.8) | 15 (65.2) | |
| Local invasion | 0.066 | |||
| T1-T2 | 26 | 17 (65.4) | 9 (34.6) | |
| T3-T4 | 23 | 9 (39.1) | 14 (60.9) | |
| Lymph node metastasis | 0.029a | |||
| 0–2 | 23 | 16 (69.6) | 7 (30.4) | |
| >2 | 26 | 10 (38.5) | 16 (61.5) | |
| Histology | 0.765 | |||
| Adenocarcinoma | 33 | 18 (54.5) | 15 (45.5) | |
| Squamous | 16 | 8 (50.0) | 8 (50.0) | |
a
P-values are calculated with Chi-square test.